标题
Selective ROCK2 inhibition in focal cerebral ischemia
作者
关键词
-
出版物
Annals of Clinical and Translational Neurology
Volume 1, Issue 1, Pages 2-14
出版商
Wiley
发表日期
2013-11-20
DOI
10.1002/acn3.19
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Characterization of long-term functional outcome in a murine model of mild brain ischemia
- (2013) Mustafa Balkaya et al. JOURNAL OF NEUROSCIENCE METHODS
- Distinct Distribution and Localization of Rho-kinase in Mouse Epithelial, Muscle and Neural Tissues
- (2012) Michiro Iizuka et al. CELL STRUCTURE AND FUNCTION
- Rho-Kinase Inhibitor, Fasudil, Prevents Neuronal Apoptosis via the Akt Activation and PTEN Inactivation in the Ischemic Penumbra of Rat Brain
- (2012) Jianhua Wu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- ROCKs as immunomodulators of stroke
- (2012) Qing Mei Wang et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator
- (2012) M. Ishiguro et al. NEUROSCIENCE
- Inhibition of Rho kinases increases directional motility of microvascular endothelial cells
- (2011) Johannes Breyer et al. BIOCHEMICAL PHARMACOLOGY
- Migraine Mutations Increase Stroke Vulnerability by Facilitating Ischemic Depolarizations
- (2011) Katharina Eikermann-Haerter et al. CIRCULATION
- Transcriptomic profiling of astrocytes treated with the Rho kinase inhibitor Fasudil reveals cytoskeletal and pro-survival responses
- (2011) Chew L. Lau et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Fasudil and Ozagrel in Combination Show Neuroprotective Effects on Cerebral Infarction after Murine Middle Cerebral Artery Occlusion
- (2011) A. Koumura et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
- (2010) Yong Zhang et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice
- (2010) Jing Ding et al. JOURNAL OF NEUROCHEMISTRY
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2010) Carol Kilkenny et al. PLOS BIOLOGY
- Behavioral deficits after distal focal cerebral ischemia in mice: Usefulness of adhesive removal test.
- (2009) Thomas Freret et al. BEHAVIORAL NEUROSCIENCE
- Rho-Associated Kinase II (ROCKII) Limits Axonal Growth after Trauma within the Adult Mouse Spinal Cord
- (2009) P. Duffy et al. JOURNAL OF NEUROSCIENCE
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
- (2009) Marc Fisher et al. STROKE
- Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth
- (2008) A. Ono et al. BLOOD
- Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin
- (2008) Marjan Boerma et al. BLOOD COAGULATION & FIBRINOLYSIS
- Targeting cerebrovascular Rho-kinase in stroke
- (2008) Hwa Kyoung Shin et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury
- (2008) Kensuke Noma et al. JOURNAL OF CLINICAL INVESTIGATION
- Local Inhibition of Rho Signaling by Cell-Permeable Recombinant Protein BA-210 Prevents Secondary Damage and Promotes Functional Recovery following Acute Spinal Cord Injury
- (2008) Stephanie Lord-Fontaine et al. JOURNAL OF NEUROTRAUMA
- Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model
- (2007) Shin-ichi Satoh et al. BRAIN RESEARCH
- Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase
- (2007) R Kast et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started